Paper37540109
Toward functionalization of ZnO nanotubes and monolayers with 5-aminolevulinic acid drugs as possible nanocarriers for drug delivery: a DFT based molecular dynamic simulation.
Mohammadzaheri M and 4 others. Phys Chem Chem Phys, 2023. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Toward functionalization of ZnO nanotubes and monolayers with 5-aminolevulinic acid drugs as possible nanocarriers for drug delivery: a DFT based molecular dynamic simulation. Papers, record 37540109. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37540109
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Toward functionalization of ZnO nanotubes and monolayers with 5-aminolevulinic acid drugs as possible nanocarriers for drug delivery: a DFT based molecular dynamic simulation.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Molecular Dynamics Simulation | Major topic |
| Zinc Oxide | Major topic |
| Aminolevulinic Acid | |
| Pharmaceutical Preparations | |
| Drug Delivery Systems |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42709248 | Transition-metal functionalization of carbon nanotubes enables dual-mode transport and rapid aqueous release of 2-mercaptopyridine: A first-principles study. | J Mol Model | 2026 | https://conductscience.org/library/papers/42709248 | PubMed |
| 41807459 | Modeling and experimental analyses for Chitosan/Zinc oxide nanocomposite. | Sci Rep | 2026 | https://conductscience.org/library/papers/41807459 | PubMed |
| 41507237 | Synthesis, spectroscopy, density functional theory study and biological activity of [Cu(phen)(L-arg)Cl]Cl·2.5H2O. | Sci Rep | 2026 | https://conductscience.org/library/papers/41507237 | PubMed |
| 40861972 | Al and Ti-doped black phosphorus as sensitive materials for adsorption of HF and H2S toxic gases: an ab initio study. | RSC Adv | 2025 | https://conductscience.org/library/papers/40861972 | PubMed |
| 40833645 | Sensing attributes of ethylbenzene and methyl ethyl ketone vapours using novel β-arsenic nitride nanosheets based on first-principles study. | J Mol Model | 2025 | https://conductscience.org/library/papers/40833645 | PubMed |
| 40560363 | Metal and metal-oxide nanoparticles inducing changes in reactive oxygen species levels and enzymes of oxidative stress: a review focused on daphnids. | Ecotoxicology | 2025 | https://conductscience.org/library/papers/40560363 | PubMed |
| 39907807 | Structures, bonding aspects and spectroscopic parameters of morin, myricetin, and quercetin with copper/zinc complexes: DFT and TDDFT exploration. | J Mol Model | 2025 | https://conductscience.org/library/papers/39907807 | PubMed |
| 39192298 | Surface modification of graphene and fullerene with Sulfur (S), Selenium (Se), and Oxygen (O): DFT Simulation for enhanced zidovudine delivery in HIV treatment. | BMC Chem | 2024 | https://conductscience.org/library/papers/39192298 | PubMed |
| 38960925 | Investigating the potential of monocyclic B9N9 and C18 rings for the electrochemical sensing, and adsorption of carbazole-based anti-cancer drug derivatives: DFT-based first-principle study. | J Mol Model | 2024 | https://conductscience.org/library/papers/38960925 | PubMed |
| 38946775 | Unveiling the influence of end-capped acceptors modification on photovoltaic properties of non-fullerene fused ring compounds: a DFT/TD-DFT study. | RSC Adv | 2024 | https://conductscience.org/library/papers/38946775 | PubMed |
| 38690114 | Enhancing corrosion resistance of mild steel in hydrochloric acid with Chiquita banana sap extract. | RSC Adv | 2024 | https://conductscience.org/library/papers/38690114 | PubMed |
| 38570356 | DFT and TDDFT exploration on electronic transitions and bonding aspect of DPA and PTDC ligated transition metal complexes. | J Mol Model | 2024 | https://conductscience.org/library/papers/38570356 | PubMed |
| 38424295 | Exploring the structural, electronic, and hydrogen storage properties of hexagonal boron nitride and carbon nanotubes: insights from single-walled to doped double-walled configurations. | Sci Rep | 2024 | https://conductscience.org/library/papers/38424295 | PubMed |
| 38403784 | The regulation of high-energy insensitive compound 2,6-diamino-3,5-dinitropyrazine-1-oxide by external electric field. | J Mol Model | 2024 | https://conductscience.org/library/papers/38403784 | PubMed |
| 38342938 | Phosphorus-doped T-graphene nanocapsule toward O3 and SO2 gas sensing: a DFT and QTAIM analysis. | Sci Rep | 2024 | https://conductscience.org/library/papers/38342938 | PubMed |
| 38259989 | Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX. | RSC Adv | 2024 | https://conductscience.org/library/papers/38259989 | PubMed |
| 37874408 | Prospective utilization of boron nitride and beryllium oxide nanotubes for Na, Li, and K-ion batteries: a DFT-based analysis. | J Mol Model | 2023 | https://conductscience.org/library/papers/37874408 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37540109
GET https://conductscience.org/api/papers/v1/37540109/authors